Protagenic Therapeutics, Inc.\new Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Protagenic Therapeutics, Inc.\new (PTIX) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $2.08 per share as of 2026-03-31, per its 10-K filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-08-14
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $2.08.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $2.87.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $3.17.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $3.72.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2026-03-31 | $2.08 10-K · filed 2026-08-14 | |
| 2025-12-31 | $2.87 10-Q · filed 2026-03-09 | |
| 2025-09-30 | $3.17 10-Q · filed 2025-11-26 | |
| 2025-06-30 | $3.72 10-QT · filed 2025-09-10 | |
| 2025-03-31 | $3.72 10-Q · filed 2026-03-09 | |
| 2024-12-31 | $26.46 10-Q · filed 2025-05-13 | $1.89 10-K · filed 2025-03-31 |
| 2024-09-30 | $2.06 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.21 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.36 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $14.72 10-K · filed 2025-03-31 | |
| 2023-09-30 | $14.43 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $14.25 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $13.89 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $13.07 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | $3.11 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.05 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $3.01 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $12.32 10-K/A · filed 2024-05-14 | $3.08 10-K · filed 2022-04-07 |
| 2021-09-30 | $3.03 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $3.02 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $2.93 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $7.00 10-K · filed 2023-03-31 | $1.75 10-K · filed 2021-03-25 |
| 2020-09-30 | $1.75 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.75 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.74 10-Q · filed 2020-06-18 | |
| 2019-12-31 | $1.74 10-K · filed 2021-03-25 | |
| 2019-09-30 | $1.43 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.43 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.68 10-Q · filed 2019-05-16 | |
| 2018-12-31 | $1.63 10-K · filed 2021-03-25 | |
| 2018-09-30 | $1.61 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.59 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.54 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.54 10-K · filed 2020-04-29 | |
| 2016-12-31 | $1.25 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |